Literature DB >> 6308846

Factors influencing the deaggregation of human and rabbit platelets.

R L Kinlough-Rathbone, J F Mustard, D W Perry, E Dejana, J P Cazenave, M A Packham, E J Harfenist.   

Abstract

The mechanisms involved in platelet deaggregation are unclear. Washed platelets from rabbits or humans aggregated by ADP can be deaggregated by EDTA or PGI2 if the release reaction has not occurred; during deaggregation 125I-fibrinogen dissociates from the platelets. Human platelets suspended in a medium without calcium undergo the release reaction during ADP-induced aggregation; EDTA, PGE1 or PGI2 do not deaggregate these platelets although EDTA displaces much of the 125I-fibrinogen that associates with them during aggregation. Rabbit platelets aggregated by low concentrations of release-inducing stimuli (sodium arachidonate, collagen or thrombin) can be deaggregated by EDTA, PGI2 or PGE1 and 125I-fibrinogen dissociates from them; with high concentrations of collagen or thrombin, deaggregation and dissociation of 125I-fibrinogen is slower. Human platelets that have undergone the release reaction in response to thrombin, collagen or a combination of sodium arachidonate and ADP are not readily deaggregated by EDTA or PGE1. Since aggregation and fibrinogen binding involving the glycoprotein IIb/IIIa complex are readily reversed by EDTA, and since Ca2+ is required for thrombospondin binding to activated platelets, there may be a third type of platelet-platelet adherence that is not disrupted by EDTA; this type of binding plays a greater role with human than with rabbit platelets.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6308846

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

1.  Aggregation-related association of lipid with the cytoskeleton of rabbit and human platelets prelabeled with [3H]palmitic acid. Similar effects of adenosine diphosphate- and thrombin-induced aggregation.

Authors:  A Livne; M A Packham; M A Guccione; J F Mustard
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

2.  Effect of forskolin on platelet deaggregation and cyclic AMP generation.

Authors:  T Kariya; F Morito; T Sakai; K Takahata; M Yamanaka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-10       Impact factor: 3.000

3.  Disaggregation and reaggregation of 'irreversibly' aggregated platelets: a method for more complete evaluation of anti-platelet drugs.

Authors:  G H Rao; J G White
Journal:  Agents Actions       Date:  1985-07

4.  Ovine platelet function and its inhibition by T-2 toxin.

Authors:  P A Gentry; A S Socha; M L Ross
Journal:  Vet Res Commun       Date:  1987       Impact factor: 2.459

5.  Comparative effects of trichothecene mycotoxins on bovine platelet function: Acetyl T-2 toxin, a more potent inhibitor than T-2 toxin.

Authors:  K Grandoni; P Gentry; B Holub; B Yagen
Journal:  Mycotoxin Res       Date:  1990-09       Impact factor: 3.833

6.  Tissue plasminogen activator promotes platelet disaggregation in plasma.

Authors:  J Loscalzo; D E Vaughan
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

7.  Platelet release reaction and aggregation induced by canatoxin, a convulsant protein: evidence for the involvement of the platelet lipoxygenase pathway.

Authors:  C R Carlini; J A Guimarães; J M Ribeiro
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

Review 8.  Detection of Platelet-Activating Antibodies Associated with Heparin-Induced Thrombocytopenia.

Authors:  Brigitte Tardy; Thomas Lecompte; François Mullier; Caroline Vayne; Claire Pouplard
Journal:  J Clin Med       Date:  2020-04-24       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.